Heart device maker wins FDA approval in major corporate boost
SYDNEY: EBR Systems, the heart device hopeful heavily backed by high-profile investors including, private equity… read more
Chemist billionaire in $297m Sigma selldown bolsters ASX turnover
MELBOURNE: Damien Gance, a director of Sigma Health and Chemist Warehouse co-founder Sam Gance’s son,… read more
Epiminder targets 2025 IPO in mayor boost to prospects
MELBOURNE: Cochlear-backed Epiminder has its sights set on an Australian initial public offering after securing… read more
